SJ Medical
SJ Medical
The global market for Liquid Embolic Agents is witnessing unprecedented growth, driven by the increasing prevalence of neurovascular diseases such as Brain Arteriovenous Malformations (AVMs), Dural Arteriovenous Fistulas (DAVFs), and hypervascular tumors. Traditionally dominated by a few multinational giants, the industry is now seeing a paradigm shift.
Modern neuro-intervention requires agents that offer controlled precipitation, high radiopacity, and excellent catheter compatibility. As surgeons move toward more complex, distal embolization, the demand for non-adhesive liquid embolic agents (like EVOH-based systems) has skyrocketed. These materials allow for longer injection times and better deep penetration compared to traditional cyanoacrylates.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
China's leading factories have transitioned from simple manufacturing to high-end innovation. Companies like SJ Medical utilize state-of-the-art cleanrooms and precision polymer synthesis to create embolic agents that rival global leaders in flow characteristics and visibility.
With massive investment in automated production lines, Chinese exporters can offer consistent supply chains even during global shortages. This scalability ensures that large-scale hospital tenders are met with on-time deliveries and rigorous batch testing.
By optimizing the supply chain and leveraging local talent, China-based manufacturers provide high-quality medical devices at a price point that makes life-saving neuro-interventional procedures more accessible in developing regions across Asia, Africa, and the Middle East.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
Global healthcare providers today look for more than just a product; they look for a strategic partner. Procurement departments in Europe and North America prioritize ISO 13485 compliance and CE marking, which SJ Medical proudly holds.
Localized Application Scenarios: In India and Southeast Asia, there is a high demand for cost-effective embolic agents for peripheral oncology (TACE procedures). In Europe, the focus shifts toward ultra-distal neurovascular access. Our products are engineered to adapt to these diverse clinical environments, ensuring compatibility with most microcatheter systems on the market.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We provide comprehensive pre-sales consultation, technical support, and responsive after-sales service to ensure every customer receives reliable solutions.
SJ Medical strictly adheres to international quality standards and regulatory requirements, demonstrating its strong commitment to product quality and compliance.
